Evidence map›Paper›PMID 41898189›Full record

ArticleBiomedicines2026

Trends of T2 and Non-T2 Cytokines During Mepolizumab Treatment in Different Asthma Patient Subgroups.

Marco Zurlo, Francesca Ambrosani, Matteo Maule, Naila Arif Cheema, Francesca Mascia, Antonino Aparo, Giuseppe Argentino, Rachele Vaia, Anna Baiocchi, Gianenrico Senna and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Marco ZurloDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-4064-070X
Francesca AmbrosaniDepartment of Medicine, University of Verona, 37134 Verona, Italy.
Matteo MauleDepartment of Medicine, University of Verona, 37134 Verona, Italy.
Naila Arif CheemaDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0009-0004-0723-435X
Francesca MasciaDepartment of Medicine, University of Verona, 37134 Verona, Italy.
Antonino AparoResearch Center LURM (Interdepartmental Laboratory of Medical Research), University of Verona, 37134 Verona, Italy.ORCID 0000-0002-4107-6680
Giuseppe ArgentinoDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-4747-4655
Rachele VaiaDepartment of Medicine, University of Verona, 37134 Verona, Italy.
Anna BaiocchiDepartment of Medicine, University of Verona, 37134 Verona, Italy.
Gianenrico SennaDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-4172-3216
Simonetta FrisoDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-9606-6711
Annalisa CastagnaDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-4650-0823
Marco CaminatiDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-7383-1487

Funding

GSK ISS 213706
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asthmaCRwNPcytokinesEGPAmepolizumab

Identifiers

PMID41898189
PMCPMC13024023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.